Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...

NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...

The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...

Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...

Scorpion Capital said in a newly-issued short report that in “20 years of shorting, TransMedics (TMDX) is the most extreme and grotesque ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...

Shares of Transmedics (NASDAQ: TMDX) fell 28.1% in December, according to data from S&P Global Market Intelligence. On Dec. 2 ...

As substantial as TransMedics' stock sell-off has been, its underlying business is by no means 63% worse. As we keep our gaze ...